A carregar...

PD-1 inhibition and treatment of advanced melanoma-role of pembrolizumab

Remarkable clinical responses have been seen in patients with metastatic melanoma with targeted therapy (BRAFi vemurafenib, MEKi) and with modern immune cell-based approaches such as TCR engineered adoptive cell transfer (ACT) and earlier experiences with high-dose IL-2. The proximal mediators of th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Cancer Res
Main Authors: Jazirehi, Ali R, Lim, Alexandra, Dinh, Tam
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5088280/
https://ncbi.nlm.nih.gov/pubmed/27822406
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!